GHRS
GH Research PLC Ordinary Shares (GHRS)
$
50About GH Research PLC Ordinary Shares (GHRS)
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Details
Daily high
$11.14
Daily low
$10.39
Price at open
$10.99
52 Week High
$20.50
52 Week Low
$6.00
Market cap
651.3M
Dividend yield
0.00%
Volume
268,715
Avg. volume
321,135
P/E ratio
-14.02
GH Research PLC Ordinary Shares News
Details
Daily high
$11.14
Daily low
$10.39
Price at open
$10.99
52 Week High
$20.50
52 Week Low
$6.00
Market cap
651.3M
Dividend yield
0.00%
Volume
268,715
Avg. volume
321,135
P/E ratio
-14.02